X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1770) 1770
Book Review (385) 385
Publication (131) 131
Book Chapter (23) 23
Conference Proceeding (6) 6
Dissertation (3) 3
Book / eBook (1) 1
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1288) 1288
humans (1089) 1089
non-inferiority (830) 830
non-inferiority trial (655) 655
female (426) 426
male (411) 411
treatment outcome (391) 391
clinical trials (382) 382
middle aged (302) 302
open-label (299) 299
pharmacology & pharmacy (293) 293
statistics & probability (262) 262
double-blind (260) 260
adult (232) 232
aged (229) 229
infectious diseases (215) 215
analysis (187) 187
drug therapy (184) 184
care and treatment (175) 175
efficacy (173) 173
oncology (173) 173
hiv infections - drug therapy (165) 165
medicine, research & experimental (164) 164
research design (161) 161
cardiac & cardiovascular systems (152) 152
equivalence (152) 152
sample size (152) 152
clinical-trials (143) 143
medicine, general & internal (135) 135
research (134) 134
safety (133) 133
confidence intervals (130) 130
non-inferiority trials (130) 130
immunology (129) 129
mathematical & computational biology (122) 122
patients (122) 122
abridged index medicus (121) 121
studies (115) 115
design (114) 114
data interpretation, statistical (112) 112
hiv (109) 109
public, environmental & occupational health (107) 107
medical informatics (106) 106
medical research (106) 106
models, statistical (105) 105
therapy (102) 102
randomized controlled-trial (101) 101
drug-eluting stents (100) 100
randomized controlled trials as topic (99) 99
risk factors (99) 99
diabetes mellitus, type 2 - drug therapy (96) 96
randomized-trial (96) 96
time factors (96) 96
endocrinology & metabolism (95) 95
health aspects (94) 94
human immunodeficiency virus--hiv (93) 93
medicine (92) 92
cancer (89) 89
usage (89) 89
thrombosis (88) 88
antiretroviral therapy (87) 87
initial treatment (87) 87
internal medicine (86) 86
comparative analysis (85) 85
diabetes (85) 85
noninferiority (85) 85
follow-up (84) 84
double-blind method (82) 82
issues (81) 81
statistics (80) 80
dosage and administration (79) 79
medicine & public health (78) 78
type 2 diabetes (78) 78
microbiology (77) 77
percutaneous coronary intervention (77) 77
drug therapy, combination (76) 76
young adult (75) 75
follow-up studies (74) 74
meta-analysis (73) 73
superiority (71) 71
anti-hiv agents - therapeutic use (69) 69
biodegradable polymer (69) 69
pharmacology (69) 69
risk (69) 69
surgery (69) 69
adolescent (68) 68
clinical trials as topic (68) 68
outcomes (68) 68
trials (68) 68
chemotherapy (67) 67
randomized controlled trials as topic - methods (67) 67
tenofovir (67) 67
animals (66) 66
hiv infections - virology (66) 66
hypoglycemic agents - therapeutic use (66) 66
co-formulated elvitegravir (65) 65
antiretroviral drugs (64) 64
medicine, experimental (64) 64
prospective studies (64) 64
clinical trials as topic - methods (63) 63
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1731) 1731
German (27) 27
French (22) 22
Spanish (10) 10
Japanese (4) 4
Italian (3) 3
Korean (3) 3
Georgian (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JAMA, ISSN 0098-7484, 12/2012, Volume 308, Issue 24, pp. 2594 - 2604
Journal Article
Circulation, ISSN 0009-7322, 2015, Volume 131, Issue 1, pp. 74 - 81
Journal Article
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 07/2013, Volume 13, Issue 1, pp. 343 - 343
Journal Article
American Heart Journal, ISSN 0002-8703, 08/2018, Volume 202, pp. 49 - 53
The Combo stent (OrbusNeich, Hoevelaken, the Netherlands) combining an abluminal, bioabsorbable polymer eluting sirolimus with a luminal CD34+ antibody to... 
DEPLOYMENT | CELLS | BIODEGRADABLE POLYMER | CARDIAC & CARDIOVASCULAR SYSTEMS | NOBORI STENT | MYOCARDIAL-INFARCTION | UNSELECTED PATIENTS | NON-INFERIORITY TRIAL | ARTERY-DISEASE | Single-Blind Method | Drug-Eluting Stents | Humans | Antibodies | Male | Coated Materials, Biocompatible | Prosthesis Design | Sirolimus - administration & dosage | Coronary Artery Disease - therapy | Antigens, CD34 - immunology | Acute Coronary Syndrome - therapy | Adult | Female | Registries | Research Design | Percutaneous Coronary Intervention | Transluminal angioplasty | Heart | Medical research | Care and treatment | Patient outcomes | Clinical trials | Coronary heart disease | Epidemiology | Stent (Surgery) | Biopharmaceutics | Viral antibodies | Cardiac patients | Medicine, Experimental | Comparative analysis | Cardiology | Myocardial infarction | Intervention | Therapy | Surgical implants | Sirolimus | Angioplasty | Bias | Medical services | Stenosis | Cardiovascular disease | Drug delivery | Clinical outcomes | Data bases | Randomization | Safety engineering | Implants | Polymers | Heart diseases | Stents | CD34 antigen | Coronary artery | Coronary artery disease | Patients | Thrombosis | Progenitor cells | Hospitals | Composite materials | Coronary vessels | Stem cells | Cells (biology) | Steel alloys | Infarction | Index Medicus | Abridged Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 03/2012, Volume 125, Issue 10, pp. 1246 - 1255
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9683, pp. 39 - 47
Summary Background Unlike most antihyperglycaemic drugs, glucagon-like peptide-1 (GLP-1) receptor agonists have a glucose-dependent action and promote weight... 
Internal Medicine | NON-INFERIORITY | METFORMIN | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | SULFONYLUREA | GLUCAGON-LIKE PEPTIDE-1 | HUMAN GLP-1 ANALOG | BETA-CELL MASS | TREATED PATIENTS | ACUTE-PANCREATITIS | INSULIN GLARGINE | Nausea - chemically induced | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Glycated Hemoglobin A - drug effects | Male | Diabetes Mellitus, Type 2 - metabolism | Weight Loss - drug effects | Dose-Response Relationship, Drug | Glucagon-Like Peptide 1 - agonists | Injections, Subcutaneous | Female | Hypoglycemia - chemically induced | Hypoglycemic Agents - therapeutic use | Drug Administration Schedule | Peptides - chemistry | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glucagon-Like Peptide 1 - chemistry | Linear Models | Logistic Models | Treatment Outcome | Hypoglycemic Agents - chemistry | Blood Glucose - drug effects | Analysis of Variance | Venoms - therapeutic use | Venoms - chemistry | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Hypoglycemic agents | Dosage and administration | Drug therapy | Molecular structure | Clinical trials | Diabetes | Clinical medicine | Apoptosis | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
American Journal of Physical Medicine & Rehabilitation, ISSN 0894-9115, 03/2019, Volume 98, Issue 3, pp. 226 - 230
ABSTRACTIn medical research, it is important to be able to examine whether there is a significant difference between two samples. With this, establishing an... 
SPORT SCIENCES | DESIGN | RANDOMIZED NON-INFERIORITY | Hypothesis Testing | Noninferiority and Equivalence Clinical Trial | REHABILITATION | CHALLENGES | PROGRAM | Superiority | Medicine, Physical | Medical research | Clinical trials